DISCONTINUOUS ORAL ABSORPTION PHARMACOKI
β
Jennifer D. Wright; Tianwei Ma; Chung K. Chu; F. Douglas Boudinot
π
Article
π
1996
π
John Wiley and Sons
π
English
β 595 KB
## 1-(2-fluoro-5-methyl-&L-arabinofuranosyl)uracil (L-FMAU) , the L isomer of FMAU, has shown potent activity against hepatitis B virus and Epstein-Barr virus. L-FMAU showed double peaks in the plasma concentration versus time profiles following oral administration to rats, indicating discontinuous